FDA Issues 510(k) Clearance to Applied Tissue Technologies’ Platform Wound Dressing (PWD®), A New Negative Pressure Wound Therapy System Without Foam or Gauze

PWD Negative Pressure Wound Therapy

Applied Tissue Technologies (ATT), an advanced wound care company, announced US FDA 510(k) clearance of its Negative Pressure Wound Therapy product, the Platform Wound Dressing (PWD®). Classified by the FDA as a class II device, the patented PWD represents the first-of-its-kind embossed negative pressure wound therapy (NPWT) device to be used without foam or gauze.